| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1543811
[patent_doc_number] => 06372958
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'Transgenic mouse with endogenous endoglin gene disruption'
[patent_app_type] => B1
[patent_app_number] => 09/578553
[patent_app_country] => US
[patent_app_date] => 2000-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 40
[patent_no_of_words] => 4785
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372958.pdf
[firstpage_image] =>[orig_patent_app_number] => 09578553
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/578553 | Transgenic mouse with endogenous endoglin gene disruption | May 24, 2000 | Issued |
Array
(
[id] => 1451657
[patent_doc_number] => 06455754
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'GENOMIC DNA FRAGMENTS CONTAINING REGULATORY AND CODING SEQUENCES FOR THE 2-SUBUNIT OF THE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AND TRANSGENIC ANIMALS MADE USING THESE FRAGMENTS OR MUTATED FRAGMENTS'
[patent_app_type] => B1
[patent_app_number] => 09/552733
[patent_app_country] => US
[patent_app_date] => 2000-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 15202
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455754.pdf
[firstpage_image] =>[orig_patent_app_number] => 09552733
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/552733 | GENOMIC DNA FRAGMENTS CONTAINING REGULATORY AND CODING SEQUENCES FOR THE 2-SUBUNIT OF THE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AND TRANSGENIC ANIMALS MADE USING THESE FRAGMENTS OR MUTATED FRAGMENTS | Apr 18, 2000 | Issued |
| 09/546411 | Growth hormone and growth hormone releasing hormone compositions | Apr 9, 2000 | Abandoned |
Array
(
[id] => 1460867
[patent_doc_number] => 06392124
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-21
[patent_title] => 'Infectious vectors and clones of plants derived from the turnip mosaic virus (TUMV)'
[patent_app_type] => B1
[patent_app_number] => 09/462569
[patent_app_country] => US
[patent_app_date] => 2000-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6259
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/392/06392124.pdf
[firstpage_image] =>[orig_patent_app_number] => 09462569
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/462569 | Infectious vectors and clones of plants derived from the turnip mosaic virus (TUMV) | Apr 2, 2000 | Issued |
| 60/266328 | Methods and compositions for treatment of diabetes and related conditons via gene therapy | Mar 14, 2000 | Pending |
| 09/424867 | COMPOSITION AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Mar 5, 2000 | Abandoned |
Array
(
[id] => 4364061
[patent_doc_number] => 06255556
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-03
[patent_title] => 'Lean transgenic animals'
[patent_app_type] => 1
[patent_app_number] => 9/500841
[patent_app_country] => US
[patent_app_date] => 2000-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4463
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/255/06255556.pdf
[firstpage_image] =>[orig_patent_app_number] => 500841
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/500841 | Lean transgenic animals | Feb 9, 2000 | Issued |
Array
(
[id] => 4335632
[patent_doc_number] => 06333186
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Modified forms of Hepatitis C NS3 protease for facilitating inhibitor screening and structural studies of protease: inhibitor complexes'
[patent_app_type] => 1
[patent_app_number] => 9/478479
[patent_app_country] => US
[patent_app_date] => 2000-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 17788
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333186.pdf
[firstpage_image] =>[orig_patent_app_number] => 478479
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/478479 | Modified forms of Hepatitis C NS3 protease for facilitating inhibitor screening and structural studies of protease: inhibitor complexes | Jan 5, 2000 | Issued |
Array
(
[id] => 1534249
[patent_doc_number] => 06489103
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-03
[patent_title] => 'In vitro sorting method'
[patent_app_type] => B1
[patent_app_number] => 09/464122
[patent_app_country] => US
[patent_app_date] => 1999-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24651
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489103.pdf
[firstpage_image] =>[orig_patent_app_number] => 09464122
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/464122 | In vitro sorting method | Dec 15, 1999 | Issued |
Array
(
[id] => 4404022
[patent_doc_number] => 06264943
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Method for transplanting cells into the brain and therapeutic uses therefor'
[patent_app_type] => 1
[patent_app_number] => 9/467549
[patent_app_country] => US
[patent_app_date] => 1999-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10722
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/264/06264943.pdf
[firstpage_image] =>[orig_patent_app_number] => 467549
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/467549 | Method for transplanting cells into the brain and therapeutic uses therefor | Dec 9, 1999 | Issued |
Array
(
[id] => 1531808
[patent_doc_number] => 06410250
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Sustained delivery device and methods of making and using the same'
[patent_app_type] => B1
[patent_app_number] => 09/451245
[patent_app_country] => US
[patent_app_date] => 1999-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19782
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410250.pdf
[firstpage_image] =>[orig_patent_app_number] => 09451245
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/451245 | Sustained delivery device and methods of making and using the same | Nov 28, 1999 | Issued |
Array
(
[id] => 4328272
[patent_doc_number] => 06312948
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells'
[patent_app_type] => 1
[patent_app_number] => 9/433322
[patent_app_country] => US
[patent_app_date] => 1999-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 18466
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/312/06312948.pdf
[firstpage_image] =>[orig_patent_app_number] => 433322
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/433322 | Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells | Nov 2, 1999 | Issued |
Array
(
[id] => 1440577
[patent_doc_number] => 06495662
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-17
[patent_title] => 'Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)'
[patent_app_type] => B1
[patent_app_number] => 09/421379
[patent_app_country] => US
[patent_app_date] => 1999-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 14900
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/495/06495662.pdf
[firstpage_image] =>[orig_patent_app_number] => 09421379
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/421379 | Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) | Oct 19, 1999 | Issued |
Array
(
[id] => 1532107
[patent_doc_number] => 06410313
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Gene delivery system and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/409650
[patent_app_country] => US
[patent_app_date] => 1999-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 24
[patent_no_of_words] => 15815
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410313.pdf
[firstpage_image] =>[orig_patent_app_number] => 09409650
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/409650 | Gene delivery system and methods of use | Sep 30, 1999 | Issued |
Array
(
[id] => 6033386
[patent_doc_number] => 20020019357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'USE OF MAGNESIUM (MG2+) FOR THE PREPARATION OF A THERAPEUTIC COMPOSITION FOR TRANSFECTION OF A POLYNUCLEOTIDE INTO A CELL AND COMPOSITIONS USEFUL IN GENE THERAPY'
[patent_app_type] => new
[patent_app_number] => 09/408947
[patent_app_country] => US
[patent_app_date] => 1999-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4216
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019357.pdf
[firstpage_image] =>[orig_patent_app_number] => 09408947
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/408947 | USE OF MAGNESIUM (MG2+) FOR THE PREPARATION OF A THERAPEUTIC COMPOSITION FOR TRANSFECTION OF A POLYNUCLEOTIDE INTO A CELL AND COMPOSITIONS USEFUL IN GENE THERAPY | Sep 29, 1999 | Abandoned |
| 09/319017 | MURINE GUANINE NUCLEOTIDE EXCHANGE FACTOR - (MNGEF) AND HUMAN HOMOLOGUES THEREOF | Sep 27, 1999 | Abandoned |
Array
(
[id] => 1587463
[patent_doc_number] => 06482406
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-19
[patent_title] => 'Cell-based gene therapy for the pulmonary system'
[patent_app_type] => B1
[patent_app_number] => 09/404652
[patent_app_country] => US
[patent_app_date] => 1999-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11820
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482406.pdf
[firstpage_image] =>[orig_patent_app_number] => 09404652
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/404652 | Cell-based gene therapy for the pulmonary system | Sep 23, 1999 | Issued |
Array
(
[id] => 4296188
[patent_doc_number] => 06251365
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Specific magnetosome, method for the production and use thereof'
[patent_app_type] => 1
[patent_app_number] => 9/397705
[patent_app_country] => US
[patent_app_date] => 1999-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2141
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251365.pdf
[firstpage_image] =>[orig_patent_app_number] => 397705
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/397705 | Specific magnetosome, method for the production and use thereof | Aug 31, 1999 | Issued |
Array
(
[id] => 4362792
[patent_doc_number] => 06191342
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-20
[patent_title] => 'Transgenic mice expressing the HIK-ras 4B chimeric gene'
[patent_app_type] => 1
[patent_app_number] => 9/355070
[patent_app_country] => US
[patent_app_date] => 1999-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 4009
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/191/06191342.pdf
[firstpage_image] =>[orig_patent_app_number] => 355070
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/355070 | Transgenic mice expressing the HIK-ras 4B chimeric gene | Jul 21, 1999 | Issued |
Array
(
[id] => 1453354
[patent_doc_number] => 06461869
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Purging leukemia cells from hematopoietic stem cells'
[patent_app_type] => B1
[patent_app_number] => 09/357752
[patent_app_country] => US
[patent_app_date] => 1999-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6160
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/461/06461869.pdf
[firstpage_image] =>[orig_patent_app_number] => 09357752
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/357752 | Purging leukemia cells from hematopoietic stem cells | Jul 19, 1999 | Issued |